Edition:
United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

24.50EUR
4:09am EST
Change (% chg)

€0.20 (+0.84%)
Prev Close
€24.29
Open
€24.20
Day's High
€24.55
Day's Low
€24.20
Volume
4,062
Avg. Vol
130,240
52-wk High
€56.94
52-wk Low
€19.80

Chart for

About

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)

Overall

Beta: 0.76
Market Cap(Mil.): €727.78
Shares Outstanding(Mil.): 29.96
Dividend: 0.29
Yield (%): 0.84

Financials

  Industry Sector
P/E (TTM): -- 28.23 15.25
EPS (TTM): -- -- --
ROI: -- 10.01 33.27
ROE: -- 15.21 16.35

BRIEF-IBA 9-month revenues at 217.3 million euros, down 3.6% ‍​

* 9M REVENUES TO 30 SEPTEMBER 2017 OF EUR 217.3 MILLION, DOWN 3.6% ‍​

Nov 16 2017

BRIEF-IBA signs global construction collaboration with Vinci

* VINCI CONSTRUCTION WILL LEAD IN THE DESIGN OF THE BUILDING AND RELATED TECHNICAL ELEMENTS‍​

Oct 10 2017

Belgium's IBA partners Vinci Construction to offer building support

Oct 10 Belgium's Ion Beam Applications (IBA) said on Tuesday it will collaborate with France's Vinci Construction to offer design and construction support to the proton therapy specialist's clients, a move designed to reduce project delays.

Oct 10 2017

BRIEF- IBA and Elekta enter MOU regarding comprehensive partnership

* ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS Source text for Eikon:

Sep 25 2017

BRIEF-Elekta and IBA partner to advance proton therapy treatments

* Eleketa and Ion Beam Applications (IBA) enter an mou regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Sep 25 2017

MOVES-ICE appoints European futures and IBA heads

LONDON, Sept 6 (IFR) - Intercontinental Exchange has appointed Stuart Williams as president of ICE Futures Europe and Timothy Bowler as president of ICE Benchmark Administration (IBA), the unit that oversees Libor. Both appointments are effective from October.

Sep 06 2017

UPDATE 1-Azerbaijan launches new bonds as part of IBA debt swap

(Adds new info, details) BAKU, Sept 1 Azerbaijan's new dollar bonds, issued as part of a restructuring of the state-run bank IBA, started trading on Friday, with two of the issues big enough to be eligible for the main emerging debt benchmark, JPMorgan EMBI Global. The International Bank of Azerbaijan (IBA) earlier this year angered investors with a plan to restructure $3.3 billion in debt and said in July it had received approval from creditors holding 93.9 percent of the a

Sep 01 2017

UPDATE 3-IBA shares dive as Belgian proton therapy group flags slower growth

Aug 24 Belgian proton therapy specialist Ion Beam Applications (IBA) lost a third of its $1 billion market value on Thursday as it cut revenue and margin guidance for 2018 and 2019, blaming project delays and increased competition.

Aug 24 2017

BRIEF-IBA H1 REBIT falls to 1.9 million euros

* H1 REVENUES EUR 151.6‍​ MILLION VERSUS EUR 145.1 MILLION YEAR AGO

Aug 24 2017

Belgium's IBA issues profit warning as project delays hit first half results

Aug 24 Belgian medical equipment company Ion Beam Applications (IBA) cut its guidance for 2018 and 2019 on Thursday, as project delays and increased competition drove the proton therapy machine maker to its third profit warning this year.

Aug 24 2017

Earnings vs. Estimates